Picard Medical, Inc. 8-K

What Happened

• Picard Medical, Inc. (PMI) filed an 8‑K on May 21, 2026 furnishing results of operations and financial condition and disclosing that the NYSE American notified the company on May 15, 2026 that it is not in compliance with continued listing standards. The exchange noted a stockholders’ deficit of approximately $1.4 million as of March 31, 2026 and losses in its three most recent fiscal years ended December 31, 2025. An earlier May 8, 2026 notice cited a separate listing standard issue and resulted in the “.BC” designation being added to PMI’s ticker.

Key Details

• NYSE American cited non‑compliance with Section 1003(a)(i) of the Company Guide (minimum $2.0M stockholders’ equity when reporting losses).
• Company must submit a written Plan to the NYSE American by June 7, 2026 to explain actions to regain compliance by November 8, 2027.
• If the Plan is accepted, PMI can remain listed during the plan period but will be subject to ongoing review; failure to submit or meet the Plan could lead to delisting procedures.
• The press release about the Notices was issued May 21, 2026 (Exhibit 99.1); trading of PMI common stock continues on NYSE American under “PMI” with the “.BC” designation and the Notices do not immediately affect trading or SEC reporting requirements.

Why It Matters

• For investors, this filing signals that PMI currently fails a key listing requirement tied to its financial condition (stockholders’ equity deficit and multi‑year losses). While trading continues for now, the company must present a credible recovery plan by June 7, 2026 and achieve compliance by November 8, 2027 to avoid delisting risk. This is material because delisting or prolonged non‑compliance could affect liquidity, investor confidence, and the marketability of PMI shares.